Park Ha Biological Technology Co. Ltd. is a holding company, which engages in the manufacture of skincare and cosmetic products. The company is headquartered in Wuxi, Jiangsu and currently employs 31 full-time employees. The company went IPO on 2024-12-27. The firm mainly operates its business through two segments. The Products Sales segment is engaged in providing skincare and cosmetic products under the brand name Park Ha as well as offering complimentary after-sales beauty services in physical stores. The Franchise Service segment is engaged in entering franchise agreements with its franchisees, pursuant to which the franchisees are granted permission to open and operate a store under the brand name Park Ha or Geni. The firm's products include Little Blue Injection Serum, Parkha Amino Acid Cleansing Foam and other products. The firm mainly conducts its business in domestic market.
Follow-Up Questions
Park Ha Biological Technology Co Ltd (PHH) 的本益比是多少?
Park Ha Biological Technology Co Ltd 的本益比是 216.4052
Park Ha Biological Technology Co Ltd 的 CEO 是誰?
Ms. Xiaoqiu Zhang 是 Park Ha Biological Technology Co Ltd 的 Chairman of the Board,自 2022 加入公司。
PHH 股票的價格表現如何?
PHH 的當前價格為 0.4925,在上個交易日 increased 了 1.13%。
Park Ha Biological Technology Co Ltd 的主要業務主題或行業是什麼?
Park Ha Biological Technology Co Ltd 屬於 Retail 行業,該板塊是 Consumer Discretionary
Park Ha Biological Technology Co Ltd 的市值是多少?
Park Ha Biological Technology Co Ltd 的當前市值是 $14.4
Park Ha Biological Technology Co Ltd 是買入、賣出還是持有?
據華爾街分析師稱,共有 0 位分析師對 Park Ha Biological Technology Co Ltd 進行了分析師評級,包括 0 位強烈買入,0 位買入,0 位持有,0 位賣出,以及 0 位強烈賣出